Antimicrobial Peptides Targeting Oral Pathogens: Applicability as an Oral Disease Treatment and Dental Material

키워드

참고문헌 (130)

1. Ageitos JM, "Antimicrobial peptides(AMPs) : ancient compounds that represent novel weapons in the fight against bacteria", Biochem Pharmacol, 133, pp.117~138 (2017)[DOI]
2. Grant M, "The human salivary antimicrobial peptide profile according to the oral microbiota in health, periodontitis and smoking", J Innate Immun, 11, pp.432~444 (2018)[DOI]
3. Raj PA, "Large-scale synthesis and functional elements for the antimicrobial activity of defensins", Biochem J, 347, pp.633~641 (2000)[DOI]
4. Joly S, "Human β-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms", J Clin Microbiol, 42, pp.1024~1029 (2004)[DOI]
5. Maisetta G, "Activity of human β-defensin 3 alone or combined with other antimicrobial agents against oral bacteria", Antimicrob Agents Chemother, 47, pp.3349~3351 (2003)[DOI]
6. Ouhara K, "Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, β-defensins and LL37, produced by human epithelial cells", J Antimicrob Chemother, 55, pp.888~896 (2005)[DOI]
7. Inomata M, "Suppressive effect of the antimicrobial peptide LL-37 on expression of IL-6, IL-8 and CXCL10 induced by Porphyromonas gingivalis cells and extracts in human gingival fibroblasts", Eur J Oral Sci, 118, pp.574~581 (2010)[DOI]
8. Tanaka D, "Sensitivity of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. to the bactericidal action of LL-37 : a cathelicidin found in human leukocytes and epithelium", Oral Microbiol Immunol, 15, pp.226~231 (2000)[DOI]
9. Oppenheim FG, "Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans", J Biol Chem, 263, pp.7472~7477 (1988)[DOI]
10. Fernández-Presas AM, "Ultrastructural damage in Streptococcus mutans incubated with saliva and histatin 5", Arch Oral Biol, 87, pp.226~234 (2018)[DOI]
11. Overhage J, "Human host defense peptide LL-37prevents bacterial biofilm formation", Infect Immun, 76, pp.4176~4182 (2008)[DOI]
12. Huan Y, "Antimicrobial peptides : classification, design, application and research progress in multiple fields", Front Microbiol, 11, pp.582779~ (2020)[DOI]
13. Shai Y, "Mode of action of membrane active antimicrobial peptides", Pept Sci, 66, pp.236~248 (2002)[DOI]
14. Yeaman MR, "Mechanisms of antimicrobial peptide action and resistance", Pharmacol Rev, 55, pp.27~55 (2003)[DOI]
15. Sato H, "Peptide–membrane interactions and mechanisms of membrane destruction by amphipathic α-helical antimicrobial peptides", Biochim Biophys Acta, 1758, pp.1245~1256 (2006)[DOI]
16. Bahar AA, "Antimicrobial peptides", Pharmaceuticals, 6, pp.1543~1575 (2013)[DOI]
17. Mardirossian M, "The host antimicrobial peptide Bac71-35 binds to bacterial ribosomal proteins and inhibits protein synthesis", Chem Biol, 21, pp.1639~1647 (2014)[DOI]
18. Graf M, "Proline-rich antimicrobial peptides targeting protein synthesis", Nat Prod Rep, 34, pp.702~711 (2017)[DOI]
19. Travkova OG, "The interaction of antimicrobial peptides with membranes", Adv Colloid Interface Sci, 247, pp.521~532 (2017)[DOI]
20. Wei L, "Structure and function of a potent lipopolysaccharide-binding antimicrobial and antiinflammatory peptide", J Med Chem, 56, pp.3546~3556 (2013)[DOI]
21. Malanovic N, "Antimicrobial peptides targeting gram-positive bacteria", Pharmaceuticals (Basel), 9, pp.59~ (2016)[DOI]
22. Epand RM, "Bacterial membrane lipids in the action of antimicrobial agents", J Pept Sci, 17, pp.298~305 (2011)[DOI]
23. Faust JE, "Action of antimicrobial peptides on bacterial and lipid membranes : a direct comparison", Biophys J, 112, pp.1663~1672 (2017)[DOI]
24. Scott MG, "The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses", J Immunol, 169, pp.3883~3891 (2002)[DOI]
25. Wiesner J, "Antimicrobial peptides : the ancient arm of the human immune system", Virulence, 1, pp.440~464 (2010)[DOI]
26. Bastos P, "Human antimicrobial peptides in bodily fluids : current knowledge and therapeutic perspectives in the postantibiotic era", Med Res Rev, 38, pp.101~146 (2018)[DOI]
27. Wang G, "Human antimicrobial peptides and proteins", Pharmaceuticals, 7, pp.545~594 (2014)[DOI]
28. Dale BA, "Antimicrobial peptides in the oral environment : expression and function in health and disease", Curr Issues Mol Biol, 7, pp.119~133 (2005)[DOI]
29. Wakabayashi H, "Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia", Antimicrob Agents Chemother, 53, pp.3308~3316 (2009)[DOI]
30. Velusamy S, "Human lactoferrin protects against Streptococcus mutansinduced caries in mice", Oral Dis, 22, pp.148~154 (2016)[DOI]
31. Schneider JJ, "Human defensins", J Mol Med (Berl), 83, pp.587~595 (2005)[DOI]
32. Jukic A, "Calprotectin : from biomarker to biological function", Gut, 70, pp.1978~1988 (2021)[DOI]
33. Wang BY, "Interactions between oral bacteria : inhibition of Streptococcus mutans bacteriocin production by Streptococcus gordonii", Appl Environ Microbiol, 71, pp.354~362 (2005)[DOI]
34. Santagati M, "Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens", FEMS Immunol Med Microbiol, 65, pp.23~31 (2012)[DOI]
35. Matsuzaki K, "Control of cell selectivity of antimicrobial peptides", Biochim Biophys Acta, 1788, pp.1687~1692 (2009)[DOI]
36. Gorr SU, "Antimicrobial peptides and periodontal disease", J Clin Periodontol, 38(Suppl 11), pp.126~141 (2011)[DOI]
37. Niu JY, "The multifaceted roles of antimicrobial peptides in oral diseases", Mol Oral Microbiol, 36, pp.159~171 (2021)[DOI]
38. Luong AD, "Important roles and potential uses of natural and synthetic antimicrobial peptides(AMPs)in oral diseases : cavity, periodontal disease, and thrush", J Funct Biomater, 13, pp.175~ (2022)[DOI]
39. Artym J, "Milk-derived proteins and peptides in clinical trials", Postepy Hig Med Dosw (Online), 67, pp.800~816 (2013)[DOI]
40. Xiong K, "Antimicrobial effect of a peptide containing novel oral spray on Streptococcus mutans", Biomed Res Int, 2020, pp.6853652~ (2020)[DOI]
41. Sun Z, "The overview of antimicrobial peptide-coated implants against oral bacterial infections", Aggregate, 4, pp.e309~ (2023)[DOI]
42. Derks J, "Peri-implant health and disease. A systematic review of current epidemiology", J Clin Periodontol, 42, pp.S158~S171 (2015)[DOI]
43. Xie SX, "Antimicrobial peptide–polymer conjugates for dentistry", ACS Appl Polym Mater, 2, pp.1134~1144 (2020)[DOI]
44. Kittaka M, "Antimicrobial peptide LL37 promotes vascular endothelial growth factor-a expression in human periodontal ligament cells", J Periodontal Res, 48, pp.228~234 (2013)[DOI]
45. Shen X, "Antibacterial and osteogenesis performances of LL37-loaded titania nanopores in vitro and in vivo", Int J Nanomedicine, 14, pp.3043~3054 (2019)[DOI]
46. Zhang L, "A tooth-binding antimicrobial peptide to prevent the formation of dental biofilm", J Mater Sci Mater Med, 30, pp.45~ (2019)[DOI]
47. Blankenvoorde MF, "Cystatin and cystatin-derived peptides have antibacterial activity against the pathogen Porphyromonas gingivalis", Biol Chem, 379, pp.1371~1375 (1998)
48. Ganeshnarayan K, "Human salivary cystatin SA exhibits antimicrobial effect against Aggregatibacter actinomycetemcomitans", J Periodontal Res, 47, pp.661~673 (2012)[DOI]
49. Blancas-Luciano BE, "Antimicrobial and anti-inflammatory activity of Cystatin C on human gingival fibroblast incubated with Porphyromonas gingivalis", PeerJ, 10, pp.e14232~ (2022)[DOI]
50. Ahn KB, "The synthetic human beta-defensin-3 C15 peptide exhibits antimicrobial activity against Streptococcus mutans, both alone and in combination with dental disinfectants", J Microbiol, 55, pp.830~836 (2017)[DOI]
51. Altman H, "In vitro assessment of antimicrobial peptides as potential agents against several oral bacteria", J Antimicrob Chemother, 58, pp.198~201 (2006)[DOI]
52. Allaker RP, "Adrenomedullin and mucosal defence : interaction between host and microorganism", Regul Pept, 112, pp.147~152 (2003)[DOI]
53. Soehnlein O, "Neutrophil-derived azurocidin alarms the immune system", J Leukoc Biol, 85, pp.344~351 (2008)[DOI]
54. Fernandes Kenya E, "Lactoferrin is broadly active against yeasts and highly synergistic with amphotericin B", Antimicrob Agents Chemother, 64, pp.e02284~19 (2020)[DOI]
55. Abrahamson M, "Human cysteine proteinase inhibitors : isolation, physiological importance, inhibitory mechanism, gene structure and relation to hereditary cerebral hemorrhage", Scand J Clin Lab Invest, 48(sup191), pp.21~31 (1988)[DOI]
56. Takahashi M, "Inhibition of growth and cysteine proteinase activity of Staphylococcus aureus V8 by phosphorylated cystatin α in skin cornified envelope", FEBS Lett, 355, pp.275~278 (1994)[DOI]
57. Powell WA, "Synthetic antimicrobial peptide design", Mol Plant Microbe Interact, 8, pp.792~794 (1995)[DOI]
58. Ong ZY, "Strategies employed in the design and optimization of synthetic antimicrobial peptide amphiphiles with enhanced therapeutic potentials", Adv Drug Deliv Rev, 78, pp.28~45 (2014)[DOI]
59. Lima PG, "Synthetic antimicrobial peptides : characteristics, design, and potential as alternative molecules to overcome microbial resistance", Life Sci, 278, pp.119647~ (2021)[DOI]
60. Chen Y, "Role of peptide hydrophobicity in the mechanism of action of α-helical antimicrobial peptides", Antimicrob Agents Chemother, 51, pp.1398~1406 (2007)[DOI]
61. Yin LM, "Roles of hydrophobicity and charge distribution of cationic antimicrobial peptides in peptide-membrane interactions", J Biol Chem, 287, pp.7738~7745 (2012)[DOI]
62. Thaker HD, "Role of amphiphilicity in the design of synthetic mimics of antimicrobial peptides with gram-negative activity", ACS Med Chem Lett, 4, pp.481~485 (2013)[DOI]
63. Sitaram N, "Interaction of antimicrobial peptides with biological and model membranes : structural and charge requirements for activity", Biochim Biophys Acta, 1462, pp.29~54 (1999)[DOI]
64. Hancock REW, "Cationic antimicrobial peptides : towards clinical applications", Expert Opin Investig Drugs, 9, pp.1723~1729 (2000)[DOI]
65. Cutrona KJ, "Role of arginine and lysine in the antimicrobial mechanism of histone-derived antimicrobial peptides", FEBS Lett, 589, pp.3915~3920 (2015)[DOI]
66. Mishra AK, "Tryptophan-rich and proline-rich antimicrobial peptides", Molecules, 23, pp.815~ (2018)[DOI]
67. Lee TH, "Antimicrobial peptide structure and mechanism of action : a focus on the role of membrane structure", Curr Top Med Chem, 16, pp.25~39 (2016)[DOI]
68. Mai XT, "Effects and mechanisms of the secondary structure on the antimicrobial activity and specificity of antimicrobial peptides", J Pept Sci, 21, pp.561~568 (2015)[DOI]
69. Chen FY, "Sigmoidal concentration dependence of antimicrobial peptide activities : a case study on alamethicin", Biophys J, 82, pp.908~914 (2002)[DOI]
70. Huang HW, "Action of antimicrobial peptides : two-state model", Biochemistry, 39, pp.8347~8352 (2000)[DOI]
71. Kotnik T, "Membrane electroporation and electropermeabilization : mechanisms and models", Annu Rev Biophys, 48, pp.63~91 (2019)[DOI]
72. Jean-François F, "Pore formation induced by an antimicrobial peptide : electrostatic effects", Biophys J, 95, pp.5748~5756 (2008)[DOI]
73. Tossi A, "Amphipathic, α-helical antimicrobial peptides", Biopolymers, 55, pp.4~30 (2000)[DOI]
74. Piers KL, "The interaction of a recombinant cecropin", melittin hybrid peptide with the outer membrane of Pseudomonas aeruginosa, 1994, pp.12, 951~958
75. Oren Z, "Mode of action of linear amphipathic α-helical antimicrobial peptides", Biopolymers, 47, pp.451~463 (1998)[DOI]
76. Shai Y, "Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by α-helical antimicrobial and cell non-selective membrane-lytic peptides", Biochim Biophys Acta, 1462, pp.55~70 (1999)[DOI]
77. Le CF, "Intracellular targeting mechanisms by antimicrobial peptides", Antimicrob Agents Chemother, 61, pp.e02340~16 (2017)[DOI]
78. Nicolas P, "Multifunctional host defense peptides : intracellular-targeting antimicrobial peptides", FEBS J, 276, pp.6483~6496 (2009)[DOI]
79. Aoki W, "Characterization of antimicrobial peptides toward the development of novel antibiotics", Pharmaceuticals, 6, pp.1055~1081 (2013)[DOI]
80. Hong SY, "Identification and characterization of novel antimicrobial decapeptides generated by combinatorial chemistry", Antimicrob Agents Chemother, 42, pp.2534~2541 (1998)[DOI]
81. Marcos JF, "Identification and rational design of novel antimicrobial peptides for plant protection", Annu Rev Phytopathol, 46, pp.273~301 (2008)[DOI]
82. Zhang C, "Antimicrobial peptides : from design to clinical application", Antibiotics, 11, pp.349~ (2022)[DOI]
83. Merrifield RB, "Synthesis of the antibacterial peptide cecropin A(1-33)", Biochemistry, 21, pp.5020~5031 (1982)[DOI]
84. Eckert R, "Road to clinical efficacy : challenges and novel strategies for antimicrobial peptide development", Future Microbiol, 6, pp.635~651 (2011)[DOI]
85. Shao C, "Antimicrobial peptides with protease stability : progress and perspective", Future Med Chem, 11, pp.2047~2050 (2019)[DOI]
86. Gan BH, "The multifaceted nature of antimicrobial peptides : current synthetic chemistry approaches and future directions", Chem Soc Rev, 50, pp.7820~7880 (2021)[DOI]
87. Franzman MR, "Targeted antimicrobial activity of a specific IgG–SMAP28 conjugate against Porphyromonas gingivalis in a mixed culture", Int J Antimicrob Agents, 33, pp.14~20 (2009)[DOI]
88. Liu Y, "Effect of the antimicrobial decapeptide KSL on the growth of oral pathogens and Streptococcus mutans biofilm", Int J Antimicrob Agents, 37, pp.33~38 (2011)[DOI]
89. Li H, "Effect of the antimicrobial peptide D-Nal-Pac-525 on the growth of Streptococcus mutans and its biofilm formation", J Microbiol Biotechnol, 23, pp.1070~1075 (2013)[DOI]
90. Wang HY, "Efficacy of a novel antimicrobial peptide against periodontal pathogens in both planktonic and polymicrobial biofilm states", Acta Biomaterialia, 25, pp.150~161 (2015)[DOI]
91. Suwandecha T, "Novel antimicrobial peptide specifically active against Porphyromonas gingivalis", Arch Microbiol, 197, pp.899~909 (2015)[DOI]
92. Tu H, "Activity of synthetic antimicrobial peptide GH12 against oral streptococci", Caries Res, 50, pp.48~61 (2016)[DOI]
93. Chen L, "A novel antimicrobial peptide against dental-caries-associated bacteria", Anaerobe, 47, pp.165~172 (2017)[DOI]
94. Maldonado A, "Purification and genetic characterization of plantaricin NC8, a novel coculture-inducible two-peptide bacteriocin from Lactobacillus plantarum NC8", Appl Environ Microbiol, 69, pp.383~389 (2003)[DOI]
95. Khalaf H, "Antibacterial effects of Lactobacillus and bacteriocin PLNC8 αβ on the periodontal pathogen Porphyromonas gingivalis", BMC Microbiol, 16, pp.188~ (2016)[DOI]
96. Taniguchi M, "Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-18 and its amino acid-substituted analogs", J Biosci Bioeng, 122, pp.652~659 (2016)[DOI]
97. Matsugishi A, "Rice peptide with amino acid substitution inhibits biofilm formation by Porphyromonas gingivalis and Fusobacterium nucleatum", Arch Oral Biol, 121, pp.104956~ (2021)[DOI]
98. Liang D, "Rational design of peptides with enhanced antimicrobial and antibiofilm activities against cariogenic bacterium Streptococcus mutans", Chem Biol Drug Des, 94, pp.1768~1781 (2019)[DOI]
99. Feng Z, "Selective antibacterial activity of a novel lactotransferrin-derived antimicrobial peptide LF-1 against Streptococcus mutans", Arch Oral Biol, 139, pp.105446~ (2022)[DOI]
100. Jiang SJ, "Antibacterial and antibiofilm activities of novel antimicrobial peptide DP7against the periodontal pathogen Porphyromonas gingivalis", J Appl Microbiol, 133, pp.1052~1062 (2022)[DOI]
101. Sullivan R, "Clinical efficacy of a specifically targeted antimicrobial peptide mouth rinse : targeted elimination of Streptococcus mutans and prevention of demineralization", Caries Res, 45, pp.415~428 (2011)[DOI]
102. Jiang S, "Antimicrobial peptide temporin derivatives inhibit biofilm formation and virulence factor expression of Streptococcus mutans", Front Microbiol, 14, pp.1267389~ (2023)[DOI]
103. Qi S, "Novel casein antimicrobial peptides for the inhibition of oral pathogenic bacteria", Food Chem, 425, pp.136454~ (2023)[DOI]
104. Kazemzadeh-Narbat M, "Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implantassociated infections", Biomaterials, 31, pp.9519~9526 (2010)[DOI]
105. Kazemzadeh-Narbat M, "Drug release and bone growth studies of antimicrobial peptideloaded calcium phosphate coating on titanium", J Biomed Mater Res B Appl Biomater, 100B, pp.1344~1352 (2012)[DOI]
106. Genco CA, "Antimicrobial activity of magainin analogues against anaerobic oral pathogens", Int J Antimicrob Agents, 21, pp.75~78 (2003)[DOI]
107. Semreen MH, "Recent updates of marine antimicrobial peptides", Saudi Pharm J, 26, pp.396~409 (2018)[DOI]
108. Moreno M, "Three valuable peptides from bee and wasp venoms for therapeutic and biotechnological use : melittin, apamin and mastoparan", Toxins, 7, pp.1126~1150 (2015)[DOI]
109. Han SM, "Antibacterial activity and antibiotic-enhancing effects of honeybee venom against methicillin-resistant Staphylococcus aureus", Molecules, 21, pp.79~ (2016)[DOI]
110. Lee G, "Anti-inflammatory applications of melittin, a major component of bee venom : detailed mechanism of action and adverse effects", Molecules, 21, pp.616~ (2016)[DOI]
111. Memariani H, "Venomderived peptide Mastoparan-1 eradicates planktonic and biofilm-embedded methicillin-resistant Staphylococcus aureus isolates", Microb Pathog, 119, pp.72~80 (2018)[DOI]
112. Piktel E, "From antimicrobial to anticancer : unraveling the potential of pleurocidin and pleurocidin-derived peptides in the treatment of cancers", Front Pharmacol, 15, pp.1340029~ (2024)[DOI]
113. El Karim IA, "Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites", J Neuroimmunol, 200, pp.11~16 (2008)[DOI]
114. Li JY, "High in vitro antibacterial activity of Pac-525 against Porphyromonas gingivalis biofilms cultured on titanium", Biomed Res Int, 2015, pp.909870~ (2015)[DOI]
115. Zhu Y, "Antimicrobial peptides, conventional antibiotics, and their synergistic utility for the treatment of drug-resistant infections", Med Res Rev, 42, pp.1377~1422 (2022)[DOI]
116. Lobos O, "In vitro antimicrobial effect of bacteriocin PsVP-10 in combination with chlorhexidine and triclosan against Streptococcus mutans and Streptococcus sobrinus strains", Arch Oral Biol, 54, pp.230~234 (2009)[DOI]
117. Andersson DI, "Persistence of antibiotic resistant bacteria", Curr Opin Microbiol, 6, pp.452~456 (2003)[DOI]
118. Hassan M, "Natural antimicrobial peptides from bacteria : characteristics and potential applications to fight against antibiotic resistance", J Appl Microbiol, 113, pp.723~736 (2012)[DOI]
119. Drexelius MG, "Application of antimicrobial peptides on biomedical implants : three ways to pursue peptide coatings", Int J Mol Sci, 22, pp.13212~ (2021)[DOI]
120. Noore J, "Cationic antimicrobial peptide LL-37 is effective against both extra-and intracellular Staphylococcus aureus", Antimicrob Agents Chemother, 57, pp.1283~1290 (2013)[DOI]
121. Pasupuleti M, "Antimicrobial peptides : key components of the innate immune system", Crit Rev Biotechnol, 32, pp.143~171 (2012)[DOI]
122. Ganz T, "The role of antimicrobial peptides in innate immunity", Integr Comp Biol, 43, pp.300~304 (2003)[DOI]
123. Cederlund A, "Antimicrobial peptides important in innate immunity", FEBS J, 278, pp.3942~3951 (2011)[DOI]
124. Lindhe J, "Group D of European Workshop on Periodontology: Peri-implant diseases: consensus report of the Sixth European Workshop on Periodontology", J Clin Periodontol, 35(8 Suppl), pp.282~285 (2008)[DOI]
125. Schwarz F, "Peri-implantitis", J Clin Periodontol, 45, pp.S246~S266 (2018)[DOI]
126. Heitz-Mayfield LJ, "The therapy of peri-implantitis: a systematic review", Int J Oral Maxillofac Implants, 29(Suppl), pp.325~345 (2014)[DOI]
127. Fang D, "A peptide coating preventing the attachment of Porphyromonas gingivalis on the surfaces of dental implants", J Periodontal Res, 55, pp.503~510 (2020)[DOI]
128. Dong H, "Surface modified techniques and emerging functional coating of dental implants", Coatings, 10, pp.1012~ (2020)[DOI]
129. Körtvélyessy G, "Bioactive coatings for dental implants : a review of alternative strategies to prevent peri-implantitis induced by anaerobic bacteria", Anaerobe, 70, pp.102404~ (2021)[DOI]
130. Geng H, "Engineered chimeric peptides with antimicrobial and titanium-binding functions to inhibit biofilm formation on Ti implants", Mater Sci Eng C Mater Biol Appl, 82, pp.141~154 (2018)[DOI]

관련 논문AI추천